Caris Life Sciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2026 Annual Meeting of Shareholders held on June 4, 2026. The filing covers the election of directors and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
As of the record date (April 9, 2026), there were 282,662,545 shares eligible to vote. A total of 273,714,520 shares were represented at the meeting, constituting a quorum.
Proposal 1: Election of Directors
All ten director nominees were elected to serve until the 2027 Annual Meeting. The voting results were as follows:
| Director Name | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| David Dean Halbert | 216,983,424 | 45,644,070 | 11,087,026 |
| Brian J. Brille | 216,953,607 | 45,673,887 | 11,087,026 |
| Peter M. Castleman | 200,435,909 | 62,191,585 | 11,087,026 |
| David Fredrickson | 228,579,061 | 34,048,433 | 11,087,026 |
| Joseph E. Gilliam | 215,798,279 | 46,829,215 | 11,087,026 |
| Jon S. Halbert | 215,600,787 | 47,026,707 | 11,087,026 |
| Laura I. Johansen | 227,201,421 | 35,426,073 | 11,087,026 |
| Dr. Lloyd B. Minor | 228,662,425 | 33,965,069 | 11,087,026 |
| Danny Phillips | 214,817,153 | 47,810,341 | 11,087,026 |
| Dr. Jeffrey Vacirca | 228,673,484 | 33,954,010 | 11,087,026 |
Proposal 2: Ratification of Independent Auditor
Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
| Votes For | Votes Against | Abstentions |
|---|---|---|
| 273,517,324 | 60,882 | 136,314 |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Meeting Date: June 4, 2026.
- Quorum Status: Achieved with 273,714,520 shares represented out of 282,662,545 eligible.
- Board Composition: All 10 nominees were successfully elected.
- Auditor: Deloitte & Touche LLP was ratified for the 2026 fiscal year.
- Financial Data: No financial performance metrics are included in this specific filing; refer to the Definitive Proxy Statement (filed April 23, 2026) or recent 10-K/10-Q filings for financial details.